Redmile Group, Director: Fate Therapeutics FATE Buy · Filed 23/04/21

Trade details

Type: Insider buy
Amount: $119,800
Shares · price: 20,000 sh · $5.99 a share
Held after: 12,879,119 sh
Stock: Fate Therapeutics FATE
Person: Redmile GroupDirector
Trade date: 23/04/20
Filed: 23/04/21
Days to filing: 1 days

2 insiders bought this week

Insiders buying this week: 2 insiders
Holding change: +0.2%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/21~23/05/20

Redmile Group's recent trades

Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$8.6M
2,634,506 sh
$8.6M
Filed 04/02
Traded 04/02
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$8.3M
2,529,491 sh
$8.3M
Filed 04/02
Traded 04/02
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$735.9K
196,229 sh
$735.9K
Filed 04/02
Traded 03/31
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$706.5K
188,407 sh
$706.5K
Filed 04/02
Traded 03/31
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$643.2K
169,265 sh
$643.2K
Filed 04/02
Traded 04/01

Redmile Group, Director — bought $119.8K of Fate Therapeutics FATE · 20,000 sh @ $5.99 | Whalegun